Literature DB >> 21562582

Senescence: Double or quit?

Darren J Burgess.   

Abstract

Year:  2011        PMID： 21562582     DOI： 10.1038/nrc3070

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis.

Authors:  Alyssa L Kennedy; Jennifer P Morton; Indrani Manoharan; David M Nelson; Nigel B Jamieson; Jeff S Pawlikowski; Tony McBryan; Brendan Doyle; Colin McKay; Karin A Oien; Greg H Enders; Rugang Zhang; Owen J Sansom; Peter D Adams
Journal:  Mol Cell       Date:  2011-04-08       Impact factor: 17.970
  1 in total
  3 in total

1.  Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus.

Authors:  Pengda Liu; Michael Begley; Wojciech Michowski; Hiroyuki Inuzuka; Miriam Ginzberg; Daming Gao; Peiling Tsou; Wenjian Gan; Antonella Papa; Byeong Mo Kim; Lixin Wan; Amrik Singh; Bo Zhai; Min Yuan; Zhiwei Wang; Steven P Gygi; Tae Ho Lee; Kun-Ping Lu; Alex Toker; Pier Paolo Pandolfi; John M Asara; Marc W Kirschner; Piotr Sicinski; Lewis Cantley; Wenyi Wei
Journal:  Nature       Date:  2014-03-09       Impact factor: 49.962

2.  CALB1 enhances the interaction between p53 and MDM2, and inhibits the senescence of ovarian cancer cells.

Authors:  Long-Qiao Cao; Ya-Nan Wang; Ming Liang; Mei-Zhou Pan
Journal:  Mol Med Rep       Date:  2019-04-30       Impact factor: 2.952

3.  Synaptotagmin-7, a binding protein of P53, inhibits the senescence and promotes the tumorigenicity of lung cancer cells.

Authors:  Zhenhua Fei; Wei Gao; Raoying Xie; Ganzhu Feng; Xiaolin Chen; Yiyan Jiang
Journal:  Biosci Rep       Date:  2019-02-08       Impact factor: 3.840
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.